Daewon Pharmaceutical Co., Ltd.

This phase 3 trial tests whether a new drug called DW1807 works better than another drug (DW1807-R2) for people with year-round allergic rhinitis who also have asthma. About 274 adults will take one of the two drugs daily for 4 weeks. The main goal is to see if DW1807 improves na…

This early-stage trial is testing how an experimental drug called DW4421 interacts with three different NSAIDs (common pain relievers like ibuprofen). The study involves 150 healthy adults aged 19 to 50. Researchers will measure safety and how the drugs move through the body to u…